Advertisement

Topics

Jean Boulle Group Company Profile

19:53 EDT 23rd June 2018 | BioPortfolio

The Jean Boulle Group Medical Division invests in promising medical technologies with funding and gives corporate and technical support. It welcomes queries.


News Articles [471 Associated News Articles listed on BioPortfolio]

The Jean Coutu Group – Special Dividend

VARENNES, Quebec, April 26, 2018 (GLOBE NEWSWIRE) -- The Jean Coutu Group (PJC) inc. (the "Corporation" or the "Jean Coutu Group") (TSX:PJC.A) announces that its Board of Directors has declared t...

The Jean Coutu Group to Hold Third Quarter of Fiscal 2018 Results Conference Call

The Jean Coutu Group to Hold Third Quarter of Fiscal 2018 Results Conference Call ...

Jean Coutu Group (PJC) Inc. 2018 Q3 - Results - Earnings Call Slides

The Jean Coutu Group – Dividend Fourth Quarter of Fiscal Year 2018

VARENNES, Québec, April 01, 2018 (GLOBE NEWSWIRE) -- The Jean Coutu Group (PJC) Inc. (the "Corporation" or the "Jean Coutu Group") (TSX:PJC.A) announces that its Board of Directors has declared ...

Ondine Biomedical Announces the Appointment of The Honourable Jean Charest, Former Premier of ...

"We are pleased and honoured that The Honourable Jean Charest has joined our Board of Directors," said Carolyn Cross, CEO and Chairman, Ondine Biomedical Read more...

Cerenis Therapeutics: Jean-Louis Dasseux

In this episode of PharmaTelevision News Review, Paul Burge talks with Jean-Louis Dasseux, CEO and President at Cerenis Therapeutics. Filmed at the PharmaTelevision studios in Oxford, UK.

Sanofi appoints Jean─Baptiste Chasseloup de Chatillon as executive VP, CFO

Sanofi has appointed Jean─Baptiste Chasseloup de Chatillon as executive vice president, chief financial officer (CFO) and member of the executive committee, effective October 1st 2018. He will join ...

Talking generics in the UK with Mylan’s Jean-Yves Brault

In 2009, the US Food and Drug Administration (FDA) accepted Mylan’s new drug application (NDA) for Brabio, the first generic...Read More... The post Talking generics in the UK with Mylan’s Jean-Yv...

PubMed Articles [1814 Associated PubMed Articles listed on BioPortfolio]

Jean-Louis Petit (1674-1750): a pioneer anatomist and surgeon and his contribution to orthopaedic surgery and trauma surgery.

The purpose of this review is to summarize the life and work of Jean-Louis Petit, his inventions, his discoveries, and his impact on the evolution of surgery of his era.

Requiem for a neurologist: the funeral rites of Jean-Martin Charcot.

Jean-Martin Charcot, the founder of modern neurology and leading figure in international neurology in the 19th century, died on August 16, 1893, in the province of Morvan in the French countryside, at...

In memoriam Professor Jean-Antoine Rioux (1925-2017).

Information and Innovation, edited by Jean P. Shipman and Barbara A. Ulmer

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

Clinical Trials [3709 Associated Clinical Trials listed on BioPortfolio]

Post Traumatic Stress Disorder and Neural Mechanisms Involved in Its Treatment

The post traumatic stress disorder PTSD arises when the physiological response to stress does not come to its term. This study aims to explore the cognitive, psycho physiological and cereb...

Patients Overexposed for a Prostate Adenocarcinoma

Background: Between 2000 and 2006, 433 patients were overexposed (8% to 10%) during a course of conformal radiotherapy for a prostate adenocarcinoma in Jean MONNET hospital, Epinal, ...

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Companies [1651 Associated Companies listed on BioPortfolio]

Jean Boulle Group

The Jean Boulle Group Medical Division invests in promising medical technologies with funding and gives corporate and technical support. It welcomes queries.

ClinOps, LLC

ClinOps, LLC is a focused contract research organization serving clients in the Biotechnology, Pharmaceutical and Medical Device industries offering expert clinical operations including strong clinica...

Thoracic Group, P.A.

Centrally headquartered in Somerset, New Jersey, Thoracic Group, P.A. is one of the country's leading providers of general thoracic and surgical services and is nationally renowned for developing and ...

Université Jean Monnet

NIL

Jean Rah Fya Records

More Information about "Jean Boulle Group" on BioPortfolio

We have published hundreds of Jean Boulle Group news stories on BioPortfolio along with dozens of Jean Boulle Group Clinical Trials and PubMed Articles about Jean Boulle Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Jean Boulle Group Companies in our database. You can also find out about relevant Jean Boulle Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record